Annex
Advisory Panel on COVID-19 Vaccines
Summary of Declaration of Interests by Members
(Position as at 27 August 2021)
Panel
Name
Proprietorships,
Remunerated employments,
Shareholdings in
Other declarable
partnerships or
offices, trades, professions or companies, public
interests
directorships of
vacations
or private (1% or
companies, public or
more of the
private
company’s issued
share capital)
Convenor
Professor LAU
Nil
1. Chair and Daniel CK Yu
Nil
Nil
Chak-sing, Wallace,
Professor, Division of
JP
Rheumatology and Clinical
Immunology, Department of
Medicine, HKU
2. Head, Department of
Medicine, HKU
3. Chief of Service, Department
of Medicine, Queen Mary
Hospital
Panel
Name
Proprietorships,
Remunerated employments,
Shareholdings in
Other declarable
partnerships or
offices, trades, professions or companies, public
interests
directorships of
vacations
or private (1% or
companies, public or
more of the
private
company’s issued
share capital)
Member Dr AU YEUNG
1. Council member of
1. Consultant, the Hong Kong
Nil
Nil
Tung-wai
The Hong Kong
Hospital Authority
Geriatrics Society
2. Part-time lecturer, CUHK
2. Council member of
The Chinese
Dementia Research
Association
3. Council member of
The Hong Kong
Specialist Medical
Association
4. Editor-in-chief of
Asian Journal of
Gerontology and
Geriatrics
The above organisations
will and have received
2
Panel
Name
Proprietorships,
Remunerated employments,
Shareholdings in
Other declarable
partnerships or
offices, trades, professions or companies, public
interests
directorships of
vacations
or private (1% or
companies, public or
more of the
private
company’s issued
share capital)
sponsorships for the
purpose of continuous
medical education from
various pharmaceutical
companies including
Pfizer and AstraZeneca.
Member Professor Keiji
Nil
Director, School of Public
Nil
Nil
FUKUDA
Health, Li Ka Shing Faculty of
Medicine, HKU
Member Professor LAU Yu- 1. Founder and
Chair Professor, Department of Nil
Principal Investigators for
lung, JP
Committee Member, Paediatrics & Adolescent
multiple industry-
Children’s
Medicine, HKU
sponsored vaccine trials
Catastrophic Disease
over many years mainly
Foundation
with GSK. As Founding
2. Executive Committee
President of Asia Pacific
Member, Society for
Society for
3
Panel
Name
Proprietorships,
Remunerated employments,
Shareholdings in
Other declarable
partnerships or
offices, trades, professions or companies, public
interests
directorships of
vacations
or private (1% or
companies, public or
more of the
private
company’s issued
share capital)
the Relief of Disabled
Immunodeficiencies,
Children
sponsorship from various
3. Founder and Board of
pharmaceutical companies,
Governors Member,
in particular CSL Behring,
Children's
have been received.
Thalassaemia
Foundation
4. Founding President,
Asia Pacific Society
for
Immunodeficiencies
Member Dr HO King-man
Serve in the Council of Ad hoc teaching in courses
Nil
Currently serves in the
the HK College of
organized by HKU, PolyU,
Councils of the following
Dermatologists, HK
CUHK
professional associations:
Society for Paediatric
1. HK Society for
Dermatology,
Paediatric Dermatology
Association for
4
Panel
Name
Proprietorships,
Remunerated employments,
Shareholdings in
Other declarable
partnerships or
offices, trades, professions or companies, public
interests
directorships of
vacations
or private (1% or
companies, public or
more of the
private
company’s issued
share capital)
Integrated Aesthetic
(non-profit making
Medicine, and Asia
organization)
Dermatological
2. HK College of
Association
Dermatologists (non-
profit making
The above organisations
organization)
might have received
3. Asian Dermatological
sponsorships from
Association (non-profit
various pharmaceutical
making organization)
companies including
4. Association for
Pfizer (but never
Integrative Aesthetic
SinoVac) in educational
Medicine, HK (in the
events or activities.
process of application
Dr HO have not
for non-profit making
received any
organization)
remuneration from these
services in these
These professional
Society/Associations.
associations may organize
5
Panel
Name
Proprietorships,
Remunerated employments,
Shareholdings in
Other declarable
partnerships or
offices, trades, professions or companies, public
interests
directorships of
vacations
or private (1% or
companies, public or
more of the
private
company’s issued
share capital)
educational activities for
local doctors or healthcare
professionals and the
industry may sponsor
overseas or local speakers
to deliver lectures or set up
exhibition booth in these
activities. As far as
Dr HO knows, Pfizer,
Astrazeneca, BioNtech,
and Sinovac seldom, if
any, sponsor or set up
booth in educational
activities organized by
these associations.
Dr HO has not received
any remuneration by
6
Panel
Name
Proprietorships,
Remunerated employments,
Shareholdings in
Other declarable
partnerships or
offices, trades, professions or companies, public
interests
directorships of
vacations
or private (1% or
companies, public or
more of the
private
company’s issued
share capital)
serving in the Councils of
these professional
associations. Asian
Dermatological
Association will sponsor
one night hotel
accommodation for him to
attend the Annual General
Meeting should it be
organised in cities outside
Hong Kong. The
sponsorship is derived
from the internal resource
of the Association.
Member Professor HUI Shu- Nil
An advisor to Roche on clinical Nil
Chairperson of the
cheong, David,
research related to Baloxavir for
organising committee for
treatment of influenza
the “CUHK Advances in
7
Panel
Name
Proprietorships,
Remunerated employments,
Shareholdings in
Other declarable
partnerships or
offices, trades, professions or companies, public
interests
directorships of
vacations
or private (1% or
companies, public or
more of the
private
company’s issued
share capital)
BBS
Medicine annual
conference” and
organising committee for
the “Hong Kong Thoracic
Society annual scientific
meeting and autumn
respiratory seminar”
Member Professor HUNG
Nil
Nil
Nil
Received honoraria as
Fan-ngai, Ivan
Advisory Board Member
for Pfizer, Roche,
AstraZeneca, MSD,
Abbvie, Ferring, Gilead
and Chong Lap
8
Panel
Name
Proprietorships,
Remunerated employments,
Shareholdings in
Other declarable
partnerships or
offices, trades, professions or companies, public
interests
directorships of
vacations
or private (1% or
companies, public or
more of the
private
company’s issued
share capital)
Member Professor Gabriel
Nil
Dean of the Faculty of Medicine Nil
1. Serve on the Health
Matthew LEUNG,
of HKU which has one COVID-
Committee of the Belt
GBS, JP
19 vaccine under development
and Road General
Chamber of Commerce,
in which one of the
committee members is
the Executive Director
of Sino
Biopharmaceutical
Limited, a listed
company in Hong Kong
which had bought a
significant stake in
Sinovac Biotech
Limited (Sinovac)
2. According to
Prof LEUNG’s
understanding,
9
Panel
Name
Proprietorships,
Remunerated employments,
Shareholdings in
Other declarable
partnerships or
offices, trades, professions or companies, public
interests
directorships of
vacations
or private (1% or
companies, public or
more of the
private
company’s issued
share capital)
BioNTech vaccine has
no relation with Pfizer
Corporation Hong
Kong Limited (“Pfizer
Hong Kong”).
However, he would like
to declare that he has a
professional
acquaintance with the
Country Manager of
Pfizer Hong Kong for a
long time
Member Professor LIANG
1. Hong Kong Medical
Hong Kong Sanatorium &
Nil
Nil
Hin-suen,
Museum
Hospital (HKSH Medical Group)
Raymond, SBS, JP 2. Hong Kong Marrow
Match Foundation
3. Hong Kong Blood
Cancer Foundation
10
Panel
Name
Proprietorships,
Remunerated employments,
Shareholdings in
Other declarable
partnerships or
offices, trades, professions or companies, public
interests
directorships of
vacations
or private (1% or
companies, public or
more of the
private
company’s issued
share capital)
4. Hong Kong Academy
of Medicine
Foundation Fund
Member Dr TSANG Ho-fai, Nil
Nil
Nil
Pfizer is one of the
Thomas
sponsors for Annual
Scientific Meetings of the
Hong Kong College of
Community Medicine of
which Dr TSANG is the
current President.
Member Professor WONG
1. Independent non-
1. Lo Shiu Kwan Kan Po Ling
Therakind Limited 1. Lead Scientist in
Chi-kei, Ian
executive director of
Endowed Professor in
(UK)
Research Programme 4.
Jacobson (Hong
Pharmacy and Head of
Laboratory of Data
Kong) since 2017
Department of Pharmacology
Discovery for Health
2. Director of Healthcare
& Pharmacy, HKU
Limited (D24H).
Innovation
2. Chair Professor of Pharmacy
InnoHK since
Practice and Medicine
November 2020
11
Panel
Name
Proprietorships,
Remunerated employments,
Shareholdings in
Other declarable
partnerships or
offices, trades, professions or companies, public
interests
directorships of
vacations
or private (1% or
companies, public or
more of the
private
company’s issued
share capital)
Technology Service
Evaluation Research,
2. Member of Independent
(London) since 2007
University College London
Scientific Advisory
(UCL) School of Pharmacy,
Committee (ISAC) for
London
Clinical Practice
Research Datalink
(CPRD) of UK
Medicines and
Healthcare Products
Regulatory Agency
(2016-2021)
3. Co-Director of Centre
for Medication
Optimisation Research
and Education at the
University College
London Hospital (Since
2016)
12
Panel
Name
Proprietorships,
Remunerated employments,
Shareholdings in
Other declarable
partnerships or
offices, trades, professions or companies, public
interests
directorships of
vacations
or private (1% or
companies, public or
more of the
private
company’s issued
share capital)
4. Specialist Advisor to
NPS Medicinewise in
Australia on
MedicineInsight (since
2018)
5. Member of Hong Kong
Pharmacy and Poisons
Board (Regulatory
Authority in Hong
Kong) (since 2018)
6. Consultant to IQVIA
(since 2018)
7. Principal investigator of
“COVID-19 Vaccines
Adverse Events
Response and
Evaluation (CARE)
Programme” funded by
13
Panel
Name
Proprietorships,
Remunerated employments,
Shareholdings in
Other declarable
partnerships or
offices, trades, professions or companies, public
interests
directorships of
vacations
or private (1% or
companies, public or
more of the
private
company’s issued
share capital)
the Food and Health
Bureau
Member Professor YUEN
1. Managing Director of 1. Clinical Professor (Chair of
Nil
1. Collaborations with the
Kwok-yung, GBS,
Centre for Virology,
Infectious Diseases),
Wantai pharmaceutical/
JP
Vaccinology and
Department of Microbiology,
Xiamen University and
Therapeutics Limited
HKU
the Changchun Bai Kai,
2. Director of The Hong 2. Service Director (Path), Hong
BCHT (長春百克)
Kong Academy of
Kong West Cluster, Hospital
pharmaceutical in the
Sciences
Authority
phase 1 clinical trial for
the HKU intranasal
Covid-19 vaccine
2. Collaboration with the
company that
manufactures the
14
Panel
Name
Proprietorships,
Remunerated employments,
Shareholdings in
Other declarable
partnerships or
offices, trades, professions or companies, public
interests
directorships of
vacations
or private (1% or
companies, public or
more of the
private
company’s issued
share capital)
intramuscular ICCOV
DNA vaccine: 广州白
云山拜迪生物医药有
限公司 Guangzhou
Baiyunshan Baidi
Biotechnology Co., Ltd
15